Prelude Therapeutics Incorporated Stock Prediction
AI-powered sentiment analysis and prediction trends for PRLD, updated each market day.
PRLD AI Sentiment
AI sees no strong directional signal for Prelude Therapeutics Incorporated stock over the next 10 market days.
Prediction date: April 30, 2026
Subscribers see precise scores, buy/sell targets, and full analytics.
About Prelude Therapeutics Incorporated
Prelude Therapeutics Incorp is a precision oncology company developing medicines in areas of high unmet need for cancer patients. Its pipeline features selective KAT6A degraders and mutant selective JAK2V617F JH2 inhibitors, new approaches to clinically validated targets with transformative potential for patients. The company is also leveraging its expertise in targeted protein degradation to discover and develop next-generation degrader antibody conjugates (DACs) with novel payloads.
Sector
Exchange
Market Cap
$356,489,152
Cap Tier
Employees
79
Headquarters
WILMINGTON, DE
Listed Since
Sept. 25, 2020
Website
PRLD Sentiment Trend — Last 30 Predictions
Sentiment zones: Bullish · Neutral · Bearish
PRLD Volatility
Prelude Therapeutics Incorporated has shown high price volatility over the last 5 trading days. High volatility means larger price swings — this can present both opportunity and risk for traders.
